Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-25-050592

EVP, General Counsel, Corp Sec sold 2,385 shares at $5.16 ($12,307)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
de Verneuil Vanina EVP, General Counsel, Corp Sec 2025-11-05 Sale 10b5-1 −2,385 $5.16 $12,307 78,210 D
Open-market sales · 2,385 sh · avg $5.16 · $12,307
Loading xslF345X05/wk-form4_1762547269.xml…